Stock Scorecard



Stock Summary for Tyra Biosciences Inc (TYRA) - $16.40 as of 3/28/2024 10:11:19 PM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TYRA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TYRA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TYRA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TYRA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TYRA

S&P 500 Gains Over 1%; Amazon Earnings Top Expectations - Cingulate ( NASDAQ:CING ) , Amazon.com ( NASDAQ:AMZN ) 2/2/2024 7:32:00 PM
Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings - Cingulate ( NASDAQ:CING ) , Apple ( NASDAQ:AAPL ) 2/2/2024 5:08:00 PM
Clorox Posts Upbeat Earnings, Joins Cigna, Deckers Outdoor And Other Big Stocks Moving Higher On Friday - Cigna Group ( NYSE:CI ) , Deckers Outdoor ( NYSE:DECK ) , Clorox ( NYSE:CLX ) 2/2/2024 3:35:00 PM
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing 2/2/2024 1:00:00 PM
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300 12/22/2023 2:00:00 PM
Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday - ReAlpha Tech Corp ( NASDAQ:AIRE ) , Chegg ( NYSE:CHGG ) 11/20/2023 3:51:00 PM
Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - MedPacto, AstraZeneca, EMD Serono, Bayer, Merck, Bristol-Myers Squibb, Inovio, Seagen, Incyte 7/31/2023 9:01:00 AM
Here's What Could Help Tyra Biosciences, Inc. ( TYRA ) Maintain Its Recent Price Strength 6/16/2023 12:50:00 PM
Wall Street Analysts Think Tyra Biosciences, Inc. ( TYRA ) Could Surge 52.22%: Read This Before Placing a Bet 6/7/2023 1:55:00 PM
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday - Alvotech ( NASDAQ:ALVO ) , Achieve Life Sciences ( NASDAQ:ACHV ) 5/23/2023 2:36:00 PM

Financial Details for TYRA

Company Overview

Ticker TYRA
Company Name Tyra Biosciences Inc
Country USA
Description Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes for cancer patients. The company is headquartered in Carlsbad, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/2/2024

Stock Price History

Last Day Price 16.40
Last Day Price Updated 3/28/2024 10:11:19 PM EST
Last Day Volume 128,535
Average Daily Volume 120,395
52-Week High 20.67
52-Week Low 10.38
Last Price to 52 Week Low 58.00%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -8.55
Free Cash Flow Ratio 14.91
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 13.80
Total Cash Per Share 1.10
Book Value Per Share Most Recent Quarter 4.75
Price to Book Ratio 4.24
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 52,521,000
Market Capitalization 861,344,400
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -24.96%
Reported EPS 12 Trailing Months -1.62
Reported EPS Past Year -1.61
Reported EPS Prior Year -1.33
Net Income Twelve Trailing Months -69,134,000
Net Income Past Year -69,134,000
Net Income Prior Year -55,325,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 58,006,000
Total Cash Past Year 58,006,000
Total Cash Prior Year 251,213,000
Net Cash Position Most Recent Quarter 57,806,000
Net Cash Position Past Year 57,806,000
Long Term Debt Past Year 200,000
Long Term Debt Prior Year 200,000
Total Debt Most Recent Quarter 200,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 204,262,000
Total Stockholder Equity Prior Year 257,829,000
Total Stockholder Equity Most Recent Quarter 204,262,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.02
MACD Signal 0.43
20-Day Bollinger Lower Band 8.81
20-Day Bollinger Middle Band 14.95
20-Day Bollinger Upper Band 21.09
Beta 1.19
RSI 43.97
50-Day SMA 14.60
200-Day SMA 0.00

System

Modified 3/27/2024 9:13:33 AM EST